{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:10:13Z","timestamp":1785798613072,"version":"3.56.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["82470734"],"award-info":[{"award-number":["82470734"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["82270740"],"award-info":[{"award-number":["82270740"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["82170710"],"award-info":[{"award-number":["82170710"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012401","name":"Beijing Science and Technology Planning Project","doi-asserted-by":"publisher","award":["20230484486"],"award-info":[{"award-number":["20230484486"]}],"id":[{"id":"10.13039\/501100012401","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2024YFC2511000"],"award-info":[{"award-number":["2024YFC2511000"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>IgA nephropathy (IgAN), the most common primary glomerulonephritis worldwide, is characterized by mesangial IgA deposition, which triggers complement activation, primarily through the alternative pathway. While complement dysregulation contributes to kidney injury and adverse outcomes, complement may also facilitate clearance of pathogenic immune complexes. Here, we compared complete complement component 3 (C3) deficiency with supplementation of complement factor H (Cfh), the principal regulator of alternative pathway, in murine IgAN models. C3 deficiency prevented complement activation but paradoxically increased glomerular IgA deposition and macrophage infiltration, resulting in complicated inflammatory response. In contrast, Cfh supplementation reduced glomerular IgA and C3 deposition, decreased inflammatory cytokine expression, attenuated macrophage infiltration, lessened glomerular area and ameliorated proteinuria while enhancing macrophage-mediated phagocytosis of circulating IgA immune complexes. Accordingly, IgAN patients with higher plasma CFH levels exhibited reduced mesangial IgA and C3 deposition alongside elevated circulating C3 levels, supporting CFH\u2019s protective role in regulating complement activation and promoting immune complex clearance. Our results reveal complement\u2019s dual role in IgAN: promoting inflammatory kidney injury while facilitating clearance of pathogenic IgA deposits. Targeted complement regulation via complement factor H supplementation, rather than complete complement inhibition via global complement component 3 knockout, achieves superior therapeutic effects by simultaneously controlling complement activation, enhancing immune complex clearance, suppressing inflammation, and reducing proteinuria. These findings identify complement factor H as a novel and promising therapeutic strategy for IgA nephropathy through targeted complement regulation.<\/jats:p>","DOI":"10.1186\/s43556-026-00463-y","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:33:35Z","timestamp":1777552415000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Complement factor H supplementation rather than complete C3 knockout provides therapeutic benefits in IgA nephropathy"],"prefix":"10.1186","volume":"7","author":[{"given":"Xianzhi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinran","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jicheng","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6776-8477","authenticated-orcid":false,"given":"Li","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"issue":"25","key":"463_CR1","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1056\/NEJMra1206793","volume":"368","author":"RJ Wyatt","year":"2013","unstructured":"Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med. 2013;368(25):2402\u201314. https:\/\/doi.org\/10.1056\/NEJMra1206793.","journal-title":"N Engl J Med"},{"issue":"6","key":"463_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2215\/CJN.0000000000000135","volume":"18","author":"D Pitcher","year":"2023","unstructured":"Pitcher D, Braddon F, Hendry B, Mercer A, Osmaston K, Saleem MA, et al. Long-term outcomes in IgA nephropathy. Clin J Am Soc Nephrol. 2023;18(6):727\u201338. https:\/\/doi.org\/10.2215\/CJN.0000000000000135.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"463_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41581-024-00885-3","volume":"21","author":"CK Cheung","year":"2025","unstructured":"Cheung CK, Alexander S, Reich HN, Selvaskandan H, Zhang H, Barratt J. The pathogenesis of IgA nephropathy and implications for treatment. Nat Rev Nephrol. 2025;21(1):9\u201323. https:\/\/doi.org\/10.1038\/s41581-024-00885-3.","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"463_CR4","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.2215\/CJN.04300321","volume":"16","author":"M Wei","year":"2021","unstructured":"Wei M, Guo WY, Xu BY, Shi SF, Liu LJ, Zhou XJ, et al. Collectin11 and complement activation in IgA nephropathy. Clin J Am Soc Nephrol. 2021;16(12):1840\u201350. https:\/\/doi.org\/10.2215\/CJN.04300321.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"463_CR5","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1124\/pharmrev.120.000072","volume":"73","author":"P Garred","year":"2021","unstructured":"Garred P, Tenner AJ, Mollnes TE. Therapeutic targeting of the complement system: From rare diseases to pandemics. Pharmacol Rev. 2021;73(2):792\u2013827. https:\/\/doi.org\/10.1124\/pharmrev.120.000072.","journal-title":"Pharmacol Rev"},{"issue":"5","key":"463_CR6","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41385-022-00534-7","volume":"15","author":"N Chaudhary","year":"2022","unstructured":"Chaudhary N, Jayaraman A, Reinhardt C, Campbell JD, Bosmann M. A single-cell lung atlas of complement genes identifies the mesothelium and epithelium as prominent sources of extrahepatic complement proteins. Mucosal Immunol. 2022;15(5):927\u201339. https:\/\/doi.org\/10.1038\/s41385-022-00534-7.","journal-title":"Mucosal Immunol"},{"issue":"1","key":"463_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/imr.13166","volume":"313","author":"L Lucientes-Continente","year":"2023","unstructured":"Lucientes-Continente L, M\u00e1rquez-Tirado B, Goicoechea de Jorge E. The Factor H protein family: the switchers of the complement alternative pathway. Immunol Rev. 2023;313(1):25\u201345. https:\/\/doi.org\/10.1111\/imr.13166.","journal-title":"Immunol Rev"},{"issue":"3","key":"463_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1055\/s-2001-15248","volume":"27","author":"PF Zipfel","year":"2001","unstructured":"Zipfel PF. Complement factor H: physiology and pathophysiology. Semin Thromb Hemost. 2001;27(3):191\u20139. https:\/\/doi.org\/10.1055\/s-2001-15248.","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"463_CR9","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/his.14318","volume":"78","author":"J Wu","year":"2021","unstructured":"Wu J, Hu Z, Wang Y, Hu D, Yang Q, Li Y, et al. Severe glomerular C3 deposition indicates severe renal lesions and a poor prognosis in patients with immunoglobulin A nephropathy. Histopathology. 2021;78(6):882\u201395. https:\/\/doi.org\/10.1111\/his.14318.","journal-title":"Histopathology"},{"issue":"7","key":"463_CR10","doi-asserted-by":"publisher","first-page":"e40495","DOI":"10.1371\/journal.pone.0040495","volume":"7","author":"SJ Kim","year":"2012","unstructured":"Kim SJ, Koo HM, Lim BJ, Oh HJ, Yoo DE, Shin DH, et al. Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy. PLoS ONE. 2012;7(7):e40495. https:\/\/doi.org\/10.1371\/journal.pone.0040495.","journal-title":"PLoS ONE"},{"issue":"12","key":"463_CR11","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.2215\/CJN.0000000000000290","volume":"18","author":"Y Kang","year":"2023","unstructured":"Kang Y, Xu B, Shi S, Zhou X, Chen P, Liu L, et al. Mesangial C3 deposition, complement-associated variant, and disease progression in IgA nephropathy. Clin J Am Soc Nephrol. 2023;18(12):1583\u201391. https:\/\/doi.org\/10.2215\/CJN.0000000000000290.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"463_CR12","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1681\/ASN.0000000534","volume":"36","author":"R Lafayette","year":"2025","unstructured":"Lafayette R, Tumlin J, Fenoglio R, Kaufeld J, P\u00e9rez Valdivia M\u00c1, Wu MS, et al. Efficacy and safety of Ravulizumab in IgA nephropathy: a phase 2 randomized double-blind placebo-controlled trial. J Am Soc Nephrol. 2025;36(4):645\u201356. https:\/\/doi.org\/10.1681\/ASN.0000000534.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"463_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1056\/NEJMoa2410316","volume":"392","author":"V Perkovic","year":"2025","unstructured":"Perkovic V, Barratt J, Rovin B, Kashihara N, Maes B, Zhang H, et al. Alternative complement pathway inhibition with Iptacopan in IgA nephropathy. N Engl J Med. 2025;392(6):531\u201343. https:\/\/doi.org\/10.1056\/NEJMoa2410316.","journal-title":"N Engl J Med"},{"issue":"11","key":"463_CR14","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1016\/j.ekir.2020.08.003","volume":"5","author":"RA Lafayette","year":"2020","unstructured":"Lafayette RA, Rovin BH, Reich HN, Tumlin JA, Floege J, Barratt J. Safety, tolerability and efficacy of Narsoplimab, a novel MASP-2 inhibitor for the treatment of IgA nephropathy. Kidney International Reports. 2020;5(11):2032\u201341. https:\/\/doi.org\/10.1016\/j.ekir.2020.08.003.","journal-title":"Kidney International Reports"},{"issue":"5","key":"463_CR15","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/ckj\/sfab294","volume":"15","author":"A Bruchfeld","year":"2022","unstructured":"Bruchfeld A, Magin H, Nachman P, Parikh S, Lafayette R, Potarca A, et al. C5a receptor inhibitor Avacopan in Immunoglobulin A nephropathy-an open-label pilot study. Clin Kidney J. 2022;15(5):922\u20138. https:\/\/doi.org\/10.1093\/ckj\/sfab294.","journal-title":"Clin Kidney J"},{"issue":"4","key":"463_CR16","doi-asserted-by":"publisher","first-page":"452","DOI":"10.2215\/CJN.0000000000000384","volume":"19","author":"J Barratt","year":"2024","unstructured":"Barratt J, Liew A, Yeo SC, Fernstr\u00f6m A, Barbour SJ, Sperati CJ, et al. Phase 2 trial of Cemdisiran in adult patients with IgA nephropathy: a randomized controlled trial. Clin J Am Soc Nephrol. 2024;19(4):452\u201362. https:\/\/doi.org\/10.2215\/CJN.0000000000000384.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"16","key":"463_CR17","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s40265-023-01940-2","volume":"83","author":"A Rajasekaran","year":"2023","unstructured":"Rajasekaran A, Green TJ, Renfrow MB, Julian BA, Novak J, Rizk DV. Current understanding of complement proteins as therapeutic targets for the treatment of Immunoglobulin A nephropathy. Drugs. 2023;83(16):1475\u201399. https:\/\/doi.org\/10.1007\/s40265-023-01940-2.","journal-title":"Drugs"},{"issue":"3","key":"463_CR18","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s12325-022-02401-0","volume":"40","author":"ES Sinnathamby","year":"2023","unstructured":"Sinnathamby ES, Issa PP, Roberts L, Norwood H, Malone K, Vemulapalli H, et al. Hereditary Angioedema: diagnosis, clinical implications, and pathophysiology. Adv Ther. 2023;40(3):814\u201327. https:\/\/doi.org\/10.1007\/s12325-022-02401-0.","journal-title":"Adv Ther"},{"issue":"6","key":"463_CR19","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1681\/ASN.2017091006","volume":"29","author":"Y Yang","year":"2018","unstructured":"Yang Y, Denton H, Davies OR, Smith-Jackson K, Kerr H, Herbert AP, et al. An engineered complement Factor H construct for treatment of C3 Glomerulopathy. J Am Soc Nephrol. 2018;29(6):1649\u201361. https:\/\/doi.org\/10.1681\/ASN.2017091006.","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"463_CR20","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.1016\/j.ymthe.2025.04.035","volume":"33","author":"LA Chew","year":"2025","unstructured":"Chew LA, Grigsby D, Hester CG, Amason J, McPherson WK, Flynn EJ 3rd, et al. Truncated complement Factor H Y402 gene therapy rescues C3 Glomerulonephritis. Mol Ther. 2025;33(8):3746\u201356. https:\/\/doi.org\/10.1016\/j.ymthe.2025.04.035.","journal-title":"Mol Ther"},{"issue":"2","key":"463_CR21","doi-asserted-by":"publisher","first-page":"912","DOI":"10.4049\/jimmunol.1300269","volume":"191","author":"M Hebecker","year":"2013","unstructured":"Hebecker M, Alba-Dom\u00ednguez M, Roumenina LT, Reuter S, Hyv\u00e4rinen S, Dragon-Durey MA, et al. An engineered construct combining complement regulatory and surface-recognition domains represents a minimal-size functional factor H. J Immunol. 2013;191(2):912\u201321. https:\/\/doi.org\/10.4049\/jimmunol.1300269.","journal-title":"J Immunol"},{"issue":"1","key":"463_CR22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1681\/ASN.0000000000000465","volume":"36","author":"R Li","year":"2025","unstructured":"Li R, Wang M, Li J, Zhu L, Xie X, Wang H, et al. Lactobacilluscasei cell wall extract and production of galactose-deficient IgA1 in a humanized IGHA1 mouse model. J Am Soc Nephrol. 2025;36(1):60\u201372. https:\/\/doi.org\/10.1681\/ASN.0000000000000465.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"463_CR23","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/ki.2014.373","volume":"87","author":"JJ Alexander","year":"2015","unstructured":"Alexander JJ, Chaves LD, Chang A, Jacob A, Ritchie M, Quigg RJ. CD11b is protective in complement-mediated immune complex glomerulonephritis. Kidney Int. 2015;87(5):930\u20139. https:\/\/doi.org\/10.1038\/ki.2014.373.","journal-title":"Kidney Int"},{"issue":"7","key":"463_CR24","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1084\/jem.20161512","volume":"214","author":"C Lood","year":"2017","unstructured":"Lood C, Arve S, Ledbetter J, Elkon KB. TLR7\/8 activation in neutrophils impairs immune complex phagocytosis through shedding of FcgRIIA. J Exp Med. 2017;214(7):2103\u201319. https:\/\/doi.org\/10.1084\/jem.20161512.","journal-title":"J Exp Med"},{"issue":"1","key":"463_CR25","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1159\/000546343","volume":"11","author":"G Wang","year":"2025","unstructured":"Wang G, Dong Y, Qiao X, Jia C, Wang J, Chen G, et al. Clinical and experimental insights into the role of NETosis in IgA Nephropathy pathogenesis. Kidney Diseases. 2025;11(1):450\u201368. https:\/\/doi.org\/10.1159\/000546343.","journal-title":"Kidney Diseases"},{"key":"463_CR26","doi-asserted-by":"publisher","first-page":"1192941","DOI":"10.3389\/fimmu.2023.1192941","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Gong Y, Xu G. The role of mononuclear phagocyte system in IgA Nephropathy: pathogenesis and prognosis. Front Immunol. 2023;14:1192941. https:\/\/doi.org\/10.3389\/fimmu.2023.1192941.","journal-title":"Front Immunol"},{"issue":"1","key":"463_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-023-00476-9","volume":"9","author":"E Stamellou","year":"2023","unstructured":"Stamellou E, Seikrit C, Tang SCW, Boor P, Tesa\u0159 V, Floege J, et al. IgA Nephropathy. Nat Rev Dis Primers. 2023;9(1):67. https:\/\/doi.org\/10.1038\/s41572-023-00476-9.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"463_CR28","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s10875-013-9970-6","volume":"34","author":"L Liu","year":"2014","unstructured":"Liu L, Zhang Y, Duan X, Peng Q, Liu Q, Zhou Y, et al. C3a, C5a renal expression and their receptors are correlated to severity of IgA Nephropathy. J Clin Immunol. 2014;34(2):224\u201332. https:\/\/doi.org\/10.1007\/s10875-013-9970-6.","journal-title":"J Clin Immunol"},{"issue":"12","key":"463_CR29","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1097\/01.asn.0000095639.56212.bf","volume":"14","author":"KN Lai","year":"2003","unstructured":"Lai KN, Tang SC, Guh JY, Chuang TD, Lam MF, Chan LY, et al. Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system. J Am Soc Nephrol. 2003;14(12):3127\u201337. https:\/\/doi.org\/10.1097\/01.asn.0000095639.56212.bf.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"463_CR30","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/j.1523-1755.2005.67116.x","volume":"67","author":"LY Chan","year":"2005","unstructured":"Chan LY, Leung JC, Tsang AW, Tang SC, Lai KN. Activation of tubular epithelial cells by mesangial-derived TNF-alpha: glomerulotubular communication in IgA Nephropathy. Kidney Int. 2005;67(2):602\u201312. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.67116.x.","journal-title":"Kidney Int"},{"issue":"8","key":"463_CR31","doi-asserted-by":"publisher","first-page":"e73425","DOI":"10.1371\/journal.pone.0073425","volume":"8","author":"L Zhu","year":"2013","unstructured":"Zhu L, Zhang Q, Shi S, Liu L, Lv J, Zhang H. Synergistic effect of mesangial cell-induced CXCL1 and TGF-\u03b21 in promoting podocyte loss in IgA Nephropathy. PLoS ONE. 2013;8(8):e73425. https:\/\/doi.org\/10.1371\/journal.pone.0073425.","journal-title":"PLoS ONE"},{"issue":"7994","key":"463_CR32","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41586-023-06816-9","volume":"625","author":"A Cui","year":"2024","unstructured":"Cui A, Huang T, Li S, Ma A, P\u00e9rez JL, Sander C, et al. Dictionary of immune responses to cytokines at single-cell resolution. Nature. 2024;625(7994):377\u201384. https:\/\/doi.org\/10.1038\/s41586-023-06816-9.","journal-title":"Nature"},{"issue":"2","key":"463_CR33","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1172\/jci110764","volume":"71","author":"JB Cornacoff","year":"1983","unstructured":"Cornacoff JB, Hebert LA, Smead WL, VanAman ME, Birmingham DJ, Waxman FJ. Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest. 1983;71(2):236\u201347. https:\/\/doi.org\/10.1172\/jci110764.","journal-title":"J Clin Invest"},{"issue":"1","key":"463_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1681\/ASN.2004090778","volume":"16","author":"JJ Alexander","year":"2005","unstructured":"Alexander JJ, Pickering MC, Haas M, Osawe I, Quigg RJ. Complement factor H limits immune complex deposition and prevents inflammation and scarring in glomeruli of mice with chronic serum sickness. J Am Soc Nephrol. 2005;16(1):52\u20137. https:\/\/doi.org\/10.1681\/ASN.2004090778.","journal-title":"J Am Soc Nephrol"},{"key":"463_CR35","doi-asserted-by":"publisher","first-page":"1239146","DOI":"10.3389\/fimmu.2023.1239146","volume":"14","author":"J Santos-L\u00f3pez","year":"2023","unstructured":"Santos-L\u00f3pez J, de la Paz K, Fern\u00e1ndez FJ, Vega MC. Structural biology of complement receptors. Front Immunol. 2023;14:1239146. https:\/\/doi.org\/10.3389\/fimmu.2023.1239146.","journal-title":"Front Immunol"},{"issue":"8","key":"463_CR36","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1056\/NEJM198608213150805","volume":"315","author":"JA Schifferli","year":"1986","unstructured":"Schifferli JA, Ng YC, Peters DK. The role of complement and its receptor in the elimination of immune complexes. N Engl J Med. 1986;315(8):488\u201395. https:\/\/doi.org\/10.1056\/NEJM198608213150805.","journal-title":"N Engl J Med"},{"issue":"1","key":"463_CR37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1365-2249.2006.03174.x","volume":"146","author":"AL Hepburn","year":"2006","unstructured":"Hepburn AL, Mason JC, Wang S, Shepherd CJ, Florey O, Haskard DO, et al. Both Fc\u03b3 and complement receptors mediate transfer of immune complexes from erythrocytes to human macrophages under physiological flow conditionsin vitro. Clin Exp Immunol. 2006;146(1):133\u201345. https:\/\/doi.org\/10.1111\/j.1365-2249.2006.03174.x.","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"463_CR38","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1093\/ndt\/gfz161","volume":"35","author":"S Park","year":"2020","unstructured":"Park S, Kim HW, Park JT, Chang TI, Kang EW, Ryu DR, et al. Relationship between complement deposition and the Oxford classification score and their combined effects on renal outcome in immunoglobulin A nephropathy. Nephrol Dial Transplant. 2020;35(12):2103\u201337. https:\/\/doi.org\/10.1093\/ndt\/gfz161.","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"463_CR39","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1172\/JCI111543","volume":"74","author":"FJ Waxman","year":"1984","unstructured":"Waxman FJ, Hebert LA, Cornacoff JB, VanAman ME, Smead WL, Kraut EH, et al. Complement depletion accelerates the clearance of immune complexes from the circulation of primates. J Clin Invest. 1984;74(4):1329\u201340. https:\/\/doi.org\/10.1172\/JCI111543.","journal-title":"J Clin Invest"},{"issue":"2","key":"463_CR40","first-page":"255","volume":"60","author":"MT Aguado","year":"1987","unstructured":"Aguado MT, Mannik M. Clearance kinetics and organ uptake of complement-solubilized immune complexes in mice. Immunology. 1987;60(2):255\u201360.","journal-title":"Immunology"},{"issue":"2","key":"463_CR41","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1046\/j.1523-1755.1998.00723.x","volume":"53","author":"RJ Quigg","year":"1998","unstructured":"Quigg RJ, Lim A, Haas M, Alexander JJ, He C, Carroll MC. Immune complex glomerulonephritis in C4- and C3-deficient mice. Kidney Int. 1998;53(2):320\u201330. https:\/\/doi.org\/10.1046\/j.1523-1755.1998.00723.x.","journal-title":"Kidney Int"},{"issue":"11","key":"463_CR42","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/sj.ki.5002235","volume":"71","author":"MA Abrera-Abeleda","year":"2007","unstructured":"Abrera-Abeleda MA, Xu Y, Pickering MC, Smith RJ, Sethi S. Mesangial immune complex glomerulonephritis due to complement factor D deficiency. Kidney Int. 2007;71(11):1142\u20137. https:\/\/doi.org\/10.1038\/sj.ki.5002235.","journal-title":"Kidney Int"},{"issue":"5","key":"463_CR43","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00281-021-00882-9","volume":"43","author":"NR Medjeral-Thomas","year":"2021","unstructured":"Medjeral-Thomas NR, Cook HT, Pickering MC. Complement activation in IgA nephropathy. Semin Immunopathol. 2021;43(5):679\u201390. https:\/\/doi.org\/10.1007\/s00281-021-00882-9.","journal-title":"Semin Immunopathol"},{"key":"463_CR44","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.semcdb.2017.12.018","volume":"85","author":"M J\u00f3zsi","year":"2019","unstructured":"J\u00f3zsi M, Schneider AE, K\u00e1rp\u00e1ti \u00c9, S\u00e1ndor N. Complement factor H family proteins in their non-canonical role as modulators of cellular functions. Semin Cell Dev Biol. 2019;85:122\u201331. https:\/\/doi.org\/10.1016\/j.semcdb.2017.12.018.","journal-title":"Semin Cell Dev Biol"},{"issue":"4","key":"463_CR45","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/ng.787","volume":"43","author":"AG Gharavi","year":"2011","unstructured":"Gharavi AG, Kiryluk K, Choi M, Li Y, Hou P, Xie J, et al. Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet. 2011;43(4):321\u20137. https:\/\/doi.org\/10.1038\/ng.787.","journal-title":"Nat Genet"},{"issue":"6","key":"463_CR46","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/ki.1987.284","volume":"32","author":"A Rifai","year":"1987","unstructured":"Rifai A, Chen A, Imai H. Complement activation in experimental IgA nephropathy: an antigen-mediated process. Kidney Int. 1987;32(6):838\u201344. https:\/\/doi.org\/10.1038\/ki.1987.284.","journal-title":"Kidney Int"},{"issue":"1","key":"463_CR47","doi-asserted-by":"publisher","first-page":"330","DOI":"10.4049\/jimmunol.151.1.330","volume":"151","author":"M F\u00e4llman","year":"1993","unstructured":"F\u00e4llman M, Andersson R, Andersson T. Signaling properties of CR3 (CD11b\/CD18) and CR1 (CD35) in relation to phagocytosis of complement-opsonized particles. J Immunol. 1993;151(1):330\u20138.","journal-title":"J Immunol"},{"issue":"2","key":"463_CR48","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1681\/ASN.2017010019","volume":"29","author":"P Jullien","year":"2018","unstructured":"Jullien P, Laurent B, Claisse G, Masson I, Dinic M, Thibaudin D, et al. Deletion variants of CFHR1 and CFHR3 associate with mesangial immune deposits but not with progression of IgA nephropathy. J Am Soc Nephrol. 2018;29(2):661\u20139. https:\/\/doi.org\/10.1681\/ASN.2017010019.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"463_CR49","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1681\/ASN.2014010096","volume":"26","author":"L Zhu","year":"2015","unstructured":"Zhu L, Zhai YL, Wang FM, Hou P, Lv JC, Xu DM, et al. Variants in complement factor H and complement factor H-related protein genes, CFHR3 and CFHR1, affect complement activation in IgA nephropathy. J Am Soc Nephrol. 2015;26(5):1195\u2013204. https:\/\/doi.org\/10.1681\/ASN.2014010096.","journal-title":"J Am Soc Nephrol"},{"key":"463_CR50","doi-asserted-by":"publisher","first-page":"114544","DOI":"10.1016\/j.intimp.2025.114544","volume":"154","author":"Y Li","year":"2025","unstructured":"Li Y, Ni X, Li X, Kang Y, Yuan X, Xu G, et al. Glomerular mesangial cells derived complement factor H regulates complement activation, influences cell proliferation, and maintains actin cytoskeleton. Int Immunopharmacol. 2025;154:114544. https:\/\/doi.org\/10.1016\/j.intimp.2025.114544.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"463_CR51","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jcmgh.2021.09.003","volume":"13","author":"HY Li","year":"2022","unstructured":"Li HY, Tang ZM, Wang Z, Lv JM, Liu XL, Liang YL, et al. C-Reactive Protein protects against Acetaminophen-induced liver injury by preventing complement overactivation. Cell Mol Gastroenterol Hepatol. 2022;13(1):289\u2013307. https:\/\/doi.org\/10.1016\/j.jcmgh.2021.09.003.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"6","key":"463_CR52","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/ki.2015.233","volume":"88","author":"EM Nichols","year":"2015","unstructured":"Nichols EM, Barbour TD, Pappworth IY, Wong EK, Palmer JM, Sheerin NS, et al. An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathy. Kidney Int. 2015;88(6):1314\u201322. https:\/\/doi.org\/10.1038\/ki.2015.233.","journal-title":"Kidney Int"},{"key":"463_CR53","doi-asserted-by":"publisher","first-page":"752916","DOI":"10.3389\/fimmu.2021.752916","volume":"12","author":"O Kamala","year":"2021","unstructured":"Kamala O, Malik TH, Hallam TM, Cox TE, Yang Y, Vyas F, et al. Homodimeric minimal Factor H: in vivo tracking and extended dosing studies in Factor H deficient mice. Front Immunol. 2021;12:752916. https:\/\/doi.org\/10.3389\/fimmu.2021.752916.","journal-title":"Front Immunol"},{"issue":"1","key":"463_CR54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/jama.2024.21972","volume":"333","author":"World Medical Association","year":"2025","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human participants. JAMA. 2025;333(1):71\u20134. https:\/\/doi.org\/10.1001\/jama.2024.21972.","journal-title":"JAMA"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00463-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00463-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00463-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:02:23Z","timestamp":1777597343000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00463-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["463"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00463-y","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki [\n                      \n                      ]. All procedures involving human participants were approved by the Ethics Committee of Peking University First Hospital (approval No. 2025R0547), and written informed consent was obtained from all patients. All animal experiments were performed following the guidelines of and with the approval of the Laboratory Animal Care and Use Committee at Peking University First Hospital (approval No. J2024096).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the Table\u00a0\n                      \n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}